These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
960 related items for PubMed ID: 15539556
1. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Thomas P, Pang Y, Filardo EJ, Dong J. Endocrinology; 2005 Feb; 146(2):624-32. PubMed ID: 15539556 [Abstract] [Full Text] [Related]
2. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. Thomas P, Dong J. J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):175-9. PubMed ID: 17088055 [Abstract] [Full Text] [Related]
3. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Filardo EJ, Quinn JA, Frackelton AR, Bland KI. Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440 [Abstract] [Full Text] [Related]
4. Estrogen signaling characteristics of Atlantic croaker G protein-coupled receptor 30 (GPR30) and evidence it is involved in maintenance of oocyte meiotic arrest. Pang Y, Dong J, Thomas P. Endocrinology; 2008 Jul; 149(7):3410-26. PubMed ID: 18420744 [Abstract] [Full Text] [Related]
5. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P. Endocrinology; 2007 Jul; 148(7):3236-45. PubMed ID: 17379646 [Abstract] [Full Text] [Related]
6. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Chen Y, Li Z, He Y, Shang D, Pan J, Wang H, Chen H, Zhu Z, Wan L, Wang X. Toxicol Appl Pharmacol; 2014 Mar 01; 275(2):176-81. PubMed ID: 24440569 [Abstract] [Full Text] [Related]
7. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling. Zhou K, Sun P, Zhang Y, You X, Li P, Wang T. Steroids; 2016 Jul 01; 111():113-120. PubMed ID: 26850467 [Abstract] [Full Text] [Related]
8. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M. Cancer Res; 2007 Feb 15; 67(4):1859-66. PubMed ID: 17308128 [Abstract] [Full Text] [Related]
9. G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production. Broselid S, Berg KA, Chavera TA, Kahn R, Clarke WP, Olde B, Leeb-Lundberg LM. J Biol Chem; 2014 Aug 08; 289(32):22117-27. PubMed ID: 24962572 [Abstract] [Full Text] [Related]
10. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S. J Biol Chem; 2004 Jun 25; 279(26):27008-16. PubMed ID: 15090535 [Abstract] [Full Text] [Related]
11. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Filardo EJ, Quinn JA, Bland KI, Frackelton AR. Mol Endocrinol; 2000 Oct 25; 14(10):1649-60. PubMed ID: 11043579 [Abstract] [Full Text] [Related]
12. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, Lappano R, Pandey DP, Picard D, Mauro L, Andò S, Maggiolini M. Endocrinology; 2008 Aug 25; 149(8):3799-808. PubMed ID: 18467441 [Abstract] [Full Text] [Related]
13. Role of G-protein-coupled estrogen receptor (GPER/GPR30) in maintenance of meiotic arrest in fish oocytes. Thomas P. J Steroid Biochem Mol Biol; 2017 Mar 25; 167():153-161. PubMed ID: 28007532 [Abstract] [Full Text] [Related]
14. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy. Girgert R, Emons G, Gründker C. Breast Cancer Res Treat; 2012 Jul 25; 134(1):199-205. PubMed ID: 22290080 [Abstract] [Full Text] [Related]
15. Nature of functional estrogen receptors at the plasma membrane. Pedram A, Razandi M, Levin ER. Mol Endocrinol; 2006 Sep 25; 20(9):1996-2009. PubMed ID: 16645038 [Abstract] [Full Text] [Related]
16. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Funakoshi T, Yanai A, Shinoda K, Kawano MM, Mizukami Y. Biochem Biophys Res Commun; 2006 Aug 04; 346(3):904-10. PubMed ID: 16780796 [Abstract] [Full Text] [Related]
17. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol. Girgert R, Emons G, Gründker C. BMC Cancer; 2014 Dec 11; 14():935. PubMed ID: 25496649 [Abstract] [Full Text] [Related]
18. Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Thomas P. Front Neuroendocrinol; 2008 May 11; 29(2):292-312. PubMed ID: 18343488 [Abstract] [Full Text] [Related]
19. Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor. Filardo EJ, Quinn JA, Sabo E. Steroids; 2008 Oct 11; 73(9-10):870-3. PubMed ID: 18289622 [Abstract] [Full Text] [Related]
20. Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer. Tutzauer J, Sjöström M, Bendahl PO, Rydén L, Fernö M, Leeb-Lundberg LMF, Alkner S. PLoS One; 2020 Oct 11; 15(4):e0231786. PubMed ID: 32302351 [Abstract] [Full Text] [Related] Page: [Next] [New Search]